Keywords:
COVID‐19; convalescent plasma; hospitalised patients; randomised controlled trial
Abstract:
Convalscent plasma (CP) was identified as a potential therapy for COVID-19 available early in the pandemic.
Convalscent plasma (CP) was identified as a potential therapy for COVID-19 available early in the pandemic.
Keywords:
COVID‐19; convalescent plasma; hospitalised patients; randomised controlled trial
Abstract:
Convalscent plasma (CP) was identified as a potential therapy for COVID-19 available early in the pandemic.